|
|
HIV Medications for HIV Prevention
Basics
News & Research
- For Post-Exposure HIV Prevention, Viread May Be Gentler Option than Retrovir (April 17, 2008)
From Reuters Health
- New Frontiers in HIV Prevention: Male Circumcision and Pre-Exposure Prophylaxis in the United States -- An Interview at CROI 2007 With Patrick Sullivan, Ph.D., and Lynn Paxton, M.D., M.P.H. (February 27, 2007)
In Exclusive Coverage of the 14th Conference on Retroviruses and Opportunistic Infections, from The Body PRO
- HIV Clinical Trial Aiming to Increase Participation of Black MSM (January 11, 2007)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
- Antiretroviral Drugs as Prevention Tools: PEP, PrEP and Prevention for Positives (September 27, 2006)
In 46th Interscience Conference on Antimicrobial Agents and Chemotherapy
- PrEP Studies Show Possible Effectiveness; Scientists Say Further Tests Must Be Completed for Confirmation (August 14, 2006)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
- Can a Pill a Day Keep HIV Away? Educators Warn Against Jumping the Gun (May 5, 2006)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- Some MSM Already Using Tenofovir as Method of HIV Prevention, Outside of Clinical Trials (December 19, 2005)
Physicians and HIV prevention experts say tenofovir has been sold in gay dance clubs around the country and prescribed by some physicians for prevention.
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
- We Must Not Let Protestors Derail Trials of Pre-Exposure Prophylaxis for HIV (September 2005)
Joep Lange, former president of the International AIDS Society, says the protests reveal a major flaw in global AIDS activism.
In PLoS Medicine
- Family Health International Ends Viread Clinical Trial in Cameroon (August 12, 2005)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
- Family Health International Will Seek Support From Gates Foundation for Tenofovir Trials to Prevent HIV (August 5, 2005)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
- Antiretroviral Drug Researchers, AIDS Advocates Fail to Reach Consensus Over Viread Trials in Developing Countries (May 24, 2005)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
- Fact Sheet on "Project T": A Safety Study of Daily Oral Tenofovir to Prevent HIV Infection in HIV-Negative Men Who Have Sex With Men (PDF) (December 2004)
Study sites are in San Francisco and Atlanta.
From San Francisco Department of Public Health
- Alternative HIV Prevention Methods: The World's Most Important AIDS Research? (November 2004)
Microbicides and pre-exposure HIV treatment may be easier to develop than vaccines and less controversial than behavioral changes.
To read PDF, click here
In Project Inform Perspective, from Project Inform
- Regrettably, Cambodia Stops Important Tenofovir Prevention Trial (August 23, 2004)
The study's cancellation is a major setback for global HIV prevention efforts, writes AIDS advocate John James.
In AIDS Treatment News, from AIDS Treatment News
- Cambodian Sex Workers Refuse to Participate in Tenofovir HIV Prevention Trial (March 30, 2004)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
- "It's OK, I'm on the AIDS Pill" (February 26, 2004)
Tenofovir (Viread) is being tested as a "morning-after" pill to prevent HIV infection. But if it's found to work, could it cause more problems than it solves?.
In Wired News
- Tenofovir as Pre-Exposure Prophylaxis (February 2003)
From American Foundation for AIDS Research
- Prevention: New Approach Will Test Tenofovir for Persons at High Risk (November 22, 2002)
A brief analysis of the study's significance for women.
In AIDS Treatment News, from AIDS Treatment News
- $6.5M Set Aside to Study Tenofovir as HIV-Prevention Pill (November 5, 2002)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
|
|
